0001181431-13-054871.txt : 20131023
0001181431-13-054871.hdr.sgml : 20131023
20131023060122
ACCESSION NUMBER: 0001181431-13-054871
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131021
FILED AS OF DATE: 20131023
DATE AS OF CHANGE: 20131023
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sorrento Therapeutics, Inc.
CENTRAL INDEX KEY: 0000850261
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 330344842
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6042 CORNERSTONE CT. WEST
STREET 2: SUITE B
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-210-3700
MAIL ADDRESS:
STREET 1: 6042 CORNERSTONE CT. WEST
STREET 2: SUITE B
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: QUIKBYTE SOFTWARE INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Uy George
CENTRAL INDEX KEY: 0001586890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52228
FILM NUMBER: 131164617
MAIL ADDRESS:
STREET 1: 435 PICCOLO
CITY: IRVINE
STATE: CA
ZIP: 92620
4
1
rrd393289.xml
FORM 4
X0306
4
2013-10-21
0
0000850261
Sorrento Therapeutics, Inc.
SRNE
0001586890
Uy George
C/O SORRENTO THERAPEUTICS, INC.
6042 CORNERSTONE CT. WEST, SUITE B
SAN DIEGO
CA
92121
0
1
0
0
Chief Commercial Officer
Convertible Note
2013-10-21
4
A
0
0
35000
A
2017-04-15
Common Stock and/or Warrants
0
0
D
George Uy purchased $35,000 principal amount of convertible notes on October 21, 2013 (the "Notes"). In the event that Sorrento Therapeutics, Inc. (the "Company") issues and sells shares of its equity securities to investors after the date of the Notes and on or before the maturity date in an equity financing with total proceeds to the Company of not less than $10,000,000, then the outstanding principal balance of the Notes shall automatically convert into such equity securities at a conversion price equal to the price per share paid by the investors purchasing the equity securities. In addition, at any time after November 30, 2013 and until the Notes are no longer outstanding, the principal amount under the Notes shall be convertible into shares of Common Stock at the option of the holder, at any time. (Continued in Footnote 2)
The principal amount of the Notes shall be converted based upon the ten (10) trading day volume weighted average closing price of the Common Stock for the trading days immediately prior to the date of receipt of notice of voluntary conversion.
/s/ George Uy
2013-10-23